Altered microRNA Expression and Immunosuppressive Cytokine Production by Regulatory T Cells of Ulcerative Colitis Patients

References

• Bacchetta R, Passerini L, Gambineri E, et al. (2006). Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest, 116(6), 1713–22.
   PubMed Web of Science ®Google Scholar
• Bartel DP. (2009). MicroRNAs: Target recognition and regulatory functions. Cell, 136(2), 215–33.
   PubMed Web of Science ®Google Scholar
• Bettini M, Vignali DA. (2009). Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol, 21(6), 612–8.
   PubMed Web of Science ®Google Scholar
• Carissimi C, Carucci N, Colombo T, et al. (2014). miR-21 is a negative modulator of T-cell activation. Biochimie, 107( Pt B), 319–26.
   PubMed Web of Science ®Google Scholar
• Chen CZ, Li L, Lodish HF, Bartel DP. (2004). MicroRNAs modulate hematopoietic lineage differentiation. Science, 303(5654), 83–6.
   PubMed Web of Science ®Google Scholar
• Chong MM, Rasmussen JP, Rudensky AY, Littman DR. (2008). The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med, 205(9), 2005–17.
   PubMed Web of Science ®Google Scholar
• Cobb BS, Hertweck A, Smith J, et al. (2006). A role for Dicer in immune regulation. J Exp Med, 203(11), 2519–27.
   PubMed Web of Science ®Google Scholar
• Collison LW, Chaturvedi V, Henderson AL, et al. (2010). IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol, 11(12), 1093–101.
   PubMed Web of Science ®Google Scholar
• Collison LW, Pillai MR, Chaturvedi V, Vignali DAA. (2009). Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol, 182(10), 6121–8.
   PubMed Web of Science ®Google Scholar
• Collison LW, Workman CJ, Kuo TT, et al. (2007). The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature, 450(7169), 566–9.
   PubMed Web of Science ®Google Scholar
• Devasthanam AS, Tomasi TB. (2014). Dicer in immune cell development and function. Immunol Invest, 43(2), 182–95.
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. (2003). Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol, 4(4), 330–6.
   PubMed Web of Science ®Google Scholar
• Gambineri E, Torgerson TR, Ochs HD. (2003). Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol, 15(4), 430–5.
   PubMed Web of Science ®Google Scholar
• Hartigan-O’Connor DJ, Poon C, Sinclair E, McCune JM. (2007). Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods, 319(1–2), 41–52.
   PubMed Web of Science ®Google Scholar
• Himmel ME, Yao Y, Orban PC, et al. (2012). Regulatory T-cell therapy for inflammatory bowel disease: More questions than answers. Immunology, 136(2), 115–22.
   PubMed Web of Science ®Google Scholar
• Huehn J, Polansky JK, Hamann A. (2009). Epigenetic control of FOXP3 expression: The key to a stable regulatory T-cell lineage? Nat Rev Immunol, 9(2), 83–9.
   Google Scholar
• Iliopoulos D, Kavousanaki M, Ioannou M, et al. (2011). The negative costimulatory molecule PD-1 modulates the balance between immunity and tolerance via miR-21. Eur J Immunol, 41 (6), 1754–63.
   PubMed Web of Science ®Google Scholar
• Kaser A, Zeissig S, Blumberg RS. (2010). Inflammatory bowel disease. Annu Rev Immunol, 28, 573–621.
   PubMed Web of Science ®Google Scholar
• Kullberg MC, Hay V, Cheever AW, et al. (2005). TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation. Eur J Immunol, 35(10), 2886–95.
   PubMed Web of Science ®Google Scholar
• Lichtiger S, Present DH, Kornbluth A, et al. (1994). Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med, 330(26), 1841–5.
   PubMed Web of Science ®Google Scholar
• Lindqvist CA, Christiansson LH, Simonsson B, et al. (2010). T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies. Immunology, 131(3), 371–6.
   PubMed Web of Science ®Google Scholar
• Liston A, Lu LF, O’Carroll D, et al. (2008). Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med, 205(9), 1993–2004.
   PubMed Web of Science ®Google Scholar
• Liu W, Putnam AL, Xu-Yu Z, et al. (2006). CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med, 203(7), 1701–11.
   PubMed Web of Science ®Google Scholar
• Lu LF, Boldin MP, Chaudhry A, et al. (2010). Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell, 142(6), 914–29.
   PubMed Web of Science ®Google Scholar
• Lu LF, Thai TH, Calado DP, et al. (2009). Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity, 30(1), 80–91.
   PubMed Web of Science ®Google Scholar
• Min M, Peng L, Yang Y, et al. (2014). MicroRNA-155 is involved in the pathogenesis of ulcerative colitis by targeting FOXO3a. Inflamm Bowel Dis, 20(4), 652–9.
   PubMed Web of Science ®Google Scholar
• Mohammadnia-Afrouzi, M, Hosseini AZ, Khalili A, et al. (2015). Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients. Autoimmunity, 1–6 (early online).
   Web of Science ®Google Scholar
• Murai M, Turovskaya O, Kim G, et al. (2009). Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol, 10(11), 1178–84.
   PubMed Web of Science ®Google Scholar
• Pauley KM, Cha S, Chan EK. (2009). MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun, 32(3–4), 189–94.
   PubMed Web of Science ®Google Scholar
• Pedersen AE, Lauritsen JP. (2009). CD25 shedding by human natural occurring CD4+CD25+ regulatory T cells does not inhibit the action of IL-2. Scand J Immunol, 70(1), 40–3.
   PubMed Web of Science ®Google Scholar
• Ranatunga, DC, Ramakrishnan A, Uprety P, et al. (2012). A protective role for human IL-10-expressing CD4+ T cells in colitis. J Immunol, 189(3), 1243–52.
   PubMed Web of Science ®Google Scholar
• Rouas R, Fayyad-Kazan H, El Zein N, et al. (2009). Human natural Treg microRNA signature: Role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol, 39(6), 1608–18.
   PubMed Web of Science ®Google Scholar
• Rubtsov YP, Rasmussen JP, Chi EY, et al. (2008). Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity, 28(4), 546–58.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. (2004). Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol, 22, 531–62.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Miyara M, Costantino CM, Hafler DA. (2010). FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol, 10(7), 490–500.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Yamaguchi T, Nomura T, Ono M. (2008). Regulatory T cells and immune tolerance. Cell, 133(5), 775–87.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc, 3(6), 1101–8.
   PubMed Web of Science ®Google Scholar
• Sheedy FJ. (2015). Turning 21: Induction of miR-21 as a key switch in the inflammatory response. Front Immunol, 6, 19.
   PubMed Web of Science ®Google Scholar
• Shevach EM. (2009). Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity, 30(5), 636–45.
   PubMed Web of Science ®Google Scholar
• Takagi T, Naito Y, Mizushima K, et al. (2010). Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis. J Gastroenterol Hepatol, 25(s1), S129–33.
   Web of Science ®Google Scholar
• Wing K, Sakaguchi S. (2010). Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol, 11(1), 7–13.
   PubMed Web of Science ®Google Scholar
• Wirtz S, Billmeier U, McHedlidze T, et al. (2011). Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology, 141(5), 1875–86.
   Google Scholar
• Xiao C, Rajewsky K. (2009). MicroRNA control in the immune system: Basic principles. Cell, 136(1), 26–36.
   PubMed Web of Science ®Google Scholar
• Xue F, Li H, Zhang J, et al. (2013). miR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation. Genes Immun, 14(2), 127–31.
   PubMed Web of Science ®Google Scholar
• Yao R, Ma YL, Liang W, et al. (2012). MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1. PLoS One, 7(10), e46082.
   PubMed Web of Science ®Google Scholar
• Zhou X, Jeker LT, Fife BT, et al. (2008). Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med, 205(9), 1983–91.
   PubMed Web of Science ®Google Scholar
• Ziegler SF. (2006). FOXP3: Of mice and men. Annu Rev Immunol, 24, 209–26.
   PubMed Web of Science ®Google Scholar